Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Comparison of two therapeutic protocols in patients with antiphospholipid antibodies and recurrent miscarriages.

Comparison of two therapeutic protocols in patients with antiphospholipid antibodies and recurrent miscarriages. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Comparison of two therapeutic protocols in patients with antiphospholipid antibodies and recurrent miscarriages. Abstract Text:

    katarina jeremi?Katarina Jeremi?,miroslava pervulovMiroslava Pervulov,miroslava gojni?Miroslava Gojni?,jelena dukanacJelena Dukanac,aleksandar ljubi?Aleksandar Ljubi?,jelena stojni?Jelena Stojni?,

    AIM: To compare the effects of two therapeutic protocols for the patients with recurrent miscarriages associated with the presence of antiphospholipid (anticardiolipin) antibodies. METHODS: A prospective observational study included 20 patients with antiphospholipid antibodies in the first group who received low-molecular heparin and aspirin. The second group of 20 patients, in addition to this therapy, received immunotherapy (intravenous immunoglobulin). Aspirin was administered at the time of a positive pregnancy test, and low-molecular heparin not before the fetal heart activity registration by ultrasound. Intravenous immunoglobulin was given prior to the conception or at the beginning of the pregnancy. We compared these groups according to the pregnancy outcomes and the occurrence of complications during pregnancy, using standard statistical tests. RESULTS: The rate of positive gestational outcome in the patients treated with aspirin and low-molecular heparin was 85% (17/20), and in the second group it was 90% (18/20). There was no significant difference in pregnancy outcomes between these groups (p > 0.05), except for the occurence of preeclampsia and thrombocytopenia, which were recorded only in the aspirin and low-molecular heparin group, but with no statistical significance (p > 0.05) compared to the second group, which received immunoglobulin additionally. CONCLUSION: There was no significant difference (p > 0.05) in pregnancy outcomes between the two studied therapeutic protocols, but the therapy with aspirin and low-molecular heparin was cheaper and easier to apply than the therapy with immunoglobulins. The results of our study confirmed that the final pathogenic mechanisms in recurrent fetal miscarriages were inflammation and thrombosis of the uteroplacental blood vessels.

    Comparison of two therapeutic protocols in patients with antiphospholipid antibodies and recurrent miscarriages. Publishing Authors By Initials

    k jeremi?K Jeremi?,m pervulovM Pervulov,m gojni?M Gojni?,j dukanacJ Dukanac,a ljubi?A Ljubi?,j stojni?J Stojni?,

    For similar diagnosis: prognosis: pregnancy outcome research abstracts see: diagnosis: prognosis: pregnancy outcome research

    PUBMED ID PMID:

    MEDLINE DATE:

    Comparison of two therapeutic protocols in patients with antiphospholipid antibodies and recurrent miscarriages. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Vojnosanitetski pregled. Military-medical and phar

    VOLUME: 62

    Page Numbers: 435-9

    Journal Abbreviation:

    ISSN: 0042-8450

    DAY: 9

    MONTH: Jun

    YEAR: 2005

    Comparison of two therapeutic protocols in patients with antiphospholipid antibodies and recurrent miscarriages. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 21530700

    Comparison of two therapeutic protocols in patients with antiphospholipid antibodies and recurrent miscarriages. Keywords Mesh Terms:

    KEYWORDS: Pregnancy Outcome

    MESH TERMS: administration & dosage

    Chemical & Substance for Abstract: Comparison of two therapeutic protocols in patients with antiphospholipid antibodies and recurrent miscarriages. Information

    Substance Name: Heparin

    Registry Number: 9005-49-6

    Grant and Affiliation Information for Comparison of two therapeutic protocols in patients with antiphospholipid antibodies and recurrent miscarriages.

    AFFILIATION: Clinical Center of Serbia, Institute of Gynecology and Obstetrics, Belgrade. jeremicj@hotmail.com

    Country: Serbia and Montenegro

    Serbia and Montenegro Research PublicationSerbia and Montenegro Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Vojnosanit Pregl

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Comparison of two therapeutic protocols in patients with antiphospholipid antibodies and recurrent miscarriages Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News